NCT04757298

Brief Summary

This study tests an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable population. This study uses an integrated research collaborative framework that facilitates dialogue among researchers, community members, and service providers as a tool for optimizing the adaptive intervention and will take place at the North Jersey Community Research Initiative (NJCRI)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
668

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 12, 2021

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

February 15, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 17, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2022

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

February 15, 2024

Completed
Last Updated

February 15, 2024

Status Verified

February 1, 2024

Enrollment Period

1.7 years

First QC Date

February 15, 2021

Results QC Date

October 13, 2023

Last Update Submit

February 14, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Stage 1: Completion of COVID-19 Test After First Randomization

    For the first stage intervention, the primary outcome is coming to the agency and completing the COVID-19 antigen test one week after completing the baseline.

    Stage 1: Within one week of completing baseline.

  • Stage 2: Reported COVID Test in Last 30 Days at 6 Months Post Baseline

    For the second stage intervention, the primary outcome is self-reported completion of COVID-19 test in the past 30 days at the follow up completed 6 months after baseline. Study participants were asked whether they had completed a COVID-19 test in the past 30 days.

    Stage 2: 6 months post baseline (4th follow up visit)

Study Arms (6)

Navigation only

OTHER

Participants are randomized to receive navigation services only.

Behavioral: Navigation Services

Navigation + Brief Counseling

OTHER

After initial randomization into NS, some participants are randomized to receive Brief Counseling (BC)

Behavioral: Navigation ServicesBehavioral: Brief Counseling

Navigation + Critical Dialogue

OTHER

After initial randomization into NS, some participants are randomized to receive Critical Dialogue (CD)

Behavioral: Navigation ServicesBehavioral: Critical Dialogue

Brochure only

OTHER

Participants are randomized to receive Brochure only.

Behavioral: Referral and Digital Brochure

Brochure + Brief Counseling

OTHER

After initial randomization to receive a brochure, some participants are randomized to receive Brief Counseling (BC)

Behavioral: Brief CounselingBehavioral: Referral and Digital Brochure

Brochure + Critical Dialogue

OTHER

After initial randomization to receive a brochure, some participants are randomized to receive Critical Dialogue (CD)

Behavioral: Critical DialogueBehavioral: Referral and Digital Brochure

Interventions

Navigation services include assessment and support with service referrals. Each participant will meet with a peer navigator in person or on Zoom Conferencing for 30 minutes to go over results from their social and health needs assessment that is retrieved from the baseline assessment. The navigator shares information about COVID-19, answers questions about testing, and makes referrals to other needed services

Navigation + Brief CounselingNavigation + Critical DialogueNavigation only

Critical Dialogue includes three one-hour-long, open-group-sessions facilitated in person or online by a trained licensed facilitator. Group critical dialogue is prompted by thematic images developed by the NCCB to foster a deeper understanding of how systematic stigma, feelings of rage as victims of discrimination, and/or apathy may impact participants' beliefs and behaviors related to COVID-19 and empower participants to make critical choices to protect their health and the health of their communities.

Brochure + Critical DialogueNavigation + Critical Dialogue

Brief Counseling is a 15-minute post-COVID-19 test session delivered by a trained licensed clinician in person or via Zoom Conferencing. In the session, the clinician shares the test results and offers recommendations and information about COVID-19 treatment and prevention.

Brochure + Brief CounselingNavigation + Brief Counseling

Referral will consist of a five-minute phone call where an outreach worker offers participants information about COVID-19 testing and encourages them to get tested within one week. A digital brochure containing NJ recommendations is e-mailed or texted to participants.

Brochure + Brief CounselingBrochure + Critical DialogueBrochure only

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • over 18 years of age
  • having high risk to contract COVID or develop related complications
  • able to speak English
  • able and willing to provide informed consent.

You may not qualify if:

  • under 18 years of age
  • not at high risk to contract COVID or develop related complications
  • unable to speak English
  • unable and unwilling to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

North Jersey Community Research Initiative

Newark, New Jersey, 07102, United States

Location

Related Publications (3)

  • Lee CA, Gamino D, Lore M, Donelson C, Windsor LC. Use of research electronic data capture (REDCap) in a sequential multiple assignment randomized trial (SMART): a practical example of automating double randomization. BMC Med Res Methodol. 2023 Jul 6;23(1):162. doi: 10.1186/s12874-023-01986-6.

  • Lee CA, Gamino D, Lore M, Donelson C, Windsor LC. Use of research electronic data capture (REDCap) in a sequential multiple assignment randomized trial (SMART): A practical example of automating double randomization. Res Sq [Preprint]. 2023 Feb 24:rs.3.rs-2573133. doi: 10.21203/rs.3.rs-2573133/v1.

  • Windsor L, Benoit E, M Pinto R, Sarol J. Optimization of a new adaptive intervention using the SMART Design to increase COVID-19 testing among people at high risk in an urban community. Trials. 2022 Apr 14;23(1):310. doi: 10.1186/s13063-022-06216-w.

MeSH Terms

Interventions

Referral and Consultation

Intervention Hierarchy (Ancestors)

Professional PracticeOrganization and AdministrationHealth Services Administration

Limitations and Caveats

Note that 46% of the sample never completed follow-up 4.

Results Point of Contact

Title
Dr. Liliane Windsor
Organization
University of Illinois Urbana Champaign

Study Officials

  • Liliane Windsor, PhD

    University of Illinois Urbana Champaign

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Model Details: SMART Design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 15, 2021

First Posted

February 17, 2021

Study Start

February 12, 2021

Primary Completion

October 25, 2022

Study Completion

October 25, 2022

Last Updated

February 15, 2024

Results First Posted

February 15, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

De-identified data can be shared upon request for research purposes and under a data sharing agreement.

Shared Documents
ICF, ANALYTIC CODE
Time Frame
Upon request after the study is complete
Access Criteria
Must sign a data sharing agreement

Locations